RE:RE:Roche to acquire Telavant for $7.1b. There is a strong underlying group of shorters & bashers working hard to suppress any good news out in Onc.
Don't believe me! Twice in the past week. Two of my posts over on another chat site have been pulled down.
neither attacked anyone. I don't do that.
Regarding SP & investor sentiment, you are 100% correct, with some broader ( time & understanding) intellect.
1. Onc is not very well followed. Only a very small % of those who do, understand or even care about the science.
2. understanding #1, it takes time for news to be interpreted & acted on.
3. Those shorting, would be doubling down to sell into the news, in efforts to keep price down.
we saw clear evidence of that this am.
4. The clinical/ trial news does not have any immediate B.D. Followup. Giving great fodder for the doom & gloom squads.
Moving forward, for those who are willing to wait a few weeks. There will be a phase 3 trial announcement & it will include some form of B.D. With Roche.
The goblet trial has/ had 4 segments.( all co- therapy with Roche)
As of today they have advanced the pancreatic cancer to phase 3, ready. Alongside endorsements & $5 million, from PanCan
and
Now the colorectal cancer has been given green light to move on to further states of trials.
again, another Roche co- therapy.
so.......l.unless they had a pre- signed deal, obviously a few weeks are needed to allow Roche time to evaluate the " value" of either owning Onc outright ( buyout) or a partnership pending the phase 3 outcomes.
Sadly , many missed a great buying opportunity this am.
The analysts will chew on newest data for a while.
Most likely won't update until after Q3 report.